SAFE (Sarpogrelate Anplone in Femoro-popliteal artery intervention Efficacy) study: study protocol for a randomized controlled trial

BACKGROUND: Sarpogrelate is expected to reduce restenosis by protecting blood vessels from oxidative stress and vascular endothelial dysfunction as well as by acting as an antiplatelet agent after endovascular treatment (EVT). This trial was designed to compare aspirin plus sustained-release (SR) sa...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Trials
Autori principali: Ahn, Sanghyun, Lee, Joongyub, Min, Seung-Kee, Ha, Jongwon, Min, Sang-il, Kim, Song-Yi, Cho, Min-Ji, Cho, Sungsin
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2017
Soggetti:
Study Protocol
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5610452/
https://ncbi.nlm.nih.gov/pubmed/28938905
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13063-017-2155-5
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi